PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Brand Name: TURI-MED
Active Ingredient: 4-Chlorodehydromethyltestosterone USP (10 mg per tablet)
Pharmacological Class: Synthetic Anabolic-Androgenic Steroid ($17\alpha$-alkylated Testosterone derivative)
Bioniche Pharma TURI-MED contains 4-Chlorodehydromethyltestosterone (Oral Turinabol), an orally active derivative of Methandrostenolone structurally altered with a 4-chloro substitution. Formulated by Bioniche Pharma to deliver balanced anabolic activity, it promotes steady, high-quality skeletal muscle accretion and strength gains without aromatic conversion into estrogen.
CLINICAL PHARMACOLOGY & MECHANISM OF ACTION
4-Chlorodehydromethyltestosterone exerts its physiological actions through high-affinity binding to cellular androgen receptors, driving positive nitrogen balance and enhanced muscle protein synthesis. Due to its unique 4-chloro alteration, Bioniche Pharma TURI-MED is completely resistant to the aromatase enzyme, preventing estrogen-mediated fluid retention, subcutaneous water accumulation, and gynecomastia.
INDICATIONS & CLINICAL USE
- Therapeutic support in medical conditions requiring gradual, steady lean tissue accretion and recovery from muscle-wasting states under professional oversight.
- Adjunctive treatment for clinical recovery following chronic catabolic states, post-surgical debilitation, or severe physical trauma using Bioniche Pharma formulations.
CONTRAINDICATIONS
- Confirmed or suspected carcinoma of the prostate gland or male breast cancer.
- Female breast carcinoma complicated by hypercalcemia, as androgenic anabolic steroids may stimulate osteolytic bone resorption.
- Pregnancy and lactation due to serious risks of fetal virilization and endocrine disruption.
- Patients with known hypersensitivity to 4-Chlorodehydromethyltestosterone or any inactive formulation excipients in Bioniche Pharma products.
ADVERSE REACTIONS & PRECAUTIONS
Side effects associated with Bioniche Pharma TURI-MED are generally dose-dependent and gender-specific:
- Endocrine & Reproductive: Suppression of endogenous pituitary-testicular axis function and natural testosterone synthesis in male patients. Women are at risk for virilization symptoms (deepening of the voice, hirsutism, clitoral enlargement) when taking dosages exceeding recommended thresholds for extended periods of Bioniche Pharma treatment.
- Hepatic & Metabolic Strain: As a $17\alpha$-alkylated oral compound, continuous clinical monitoring of hepatic enzymes and serum lipid profiles (LDL elevation and HDL reduction) is recommended during Bioniche Pharma therapy.
- Dermatological, Gastrointestinal & Behavioral: Infrequent occurrences of acne vulgaris, gastrointestinal discomfort or nausea, and potential shifts in mood or aggression. Increased libido is reported in both sexes during Bioniche Pharma administration.
DOSAGE & ADMINISTRATION
Dosing protocols for Bioniche Pharma TURI-MED must be individually determined and strictly supervised by a qualified physician, taking into consideration therapeutic objectives, sex, and diagnostic laboratory monitoring.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry place away from direct light exposure, heat, and moisture. Keep strictly out of reach and sight of children.